» Articles » PMID: 35584401

Membrane Targeting Enhances Muramyl Dipeptide Binding to NOD2 and Arf6-GTPase in Mammalian Cells

Overview
Specialty Chemistry
Date 2022 May 18
PMID 35584401
Authors
Affiliations
Soon will be listed here.
Abstract

To further understand the mechanisms of muramyl dipeptide (MDP) sensing by NOD2, we evaluated key properties involved in the formation of the Arf6-MDP-NOD2 complex in mammalian cells. We found that the conserved Arf aromatic triad is crucial for binding to MDP-NOD2. Mutation of Arf6 N-myristoylation and NOD2 S-palmitoylation also abrogated the formation of the Arf6-MDP-NOD2 complex. Notably, lipid-modified MDP (L18-MDP) increased Arf6-NOD2 assembly. Our results indicate recruitment of Arf6 may explain enhanced activity of lipidated MDP analogues and membrane targeting may be important in developing next-generation NOD2 agonists.

Citing Articles

Nano-adjuvant based on lipo-imiquimod self-assembly for enhanced foot-and-mouth disease virus vaccine immune responses intradermal immunization.

Yin W, Xu Z, Ma F, Deng B, Zhao Y, Zuo X Mater Today Bio. 2025; 31:101567.

PMID: 40040795 PMC: 11876772. DOI: 10.1016/j.mtbio.2025.101567.


Distinctive Immune Signatures Driven by Structural Alterations in Desmuramylpeptide NOD2 Agonists.

Janez S, Guzelj S, Kocbek P, de Vlieger E, Slutter B, Jakopin Z J Med Chem. 2024; 67(19):17585-17607.

PMID: 39344184 PMC: 11472310. DOI: 10.1021/acs.jmedchem.4c01577.


Small molecule modulators of immune pattern recognition receptors.

Tsukidate T, Hespen C, Hang H RSC Chem Biol. 2023; 4(12):1014-1036.

PMID: 38033733 PMC: 10685800. DOI: 10.1039/d3cb00096f.


Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity.

Guzelj S, Sisic M, Bizjak S, Frkanec L, Frkanec R, Jakopin Z Pharmaceutics. 2022; 14(12).

PMID: 36559249 PMC: 9785857. DOI: 10.3390/pharmaceutics14122755.


Bacterial subversion of NLR-mediated immune responses.

Kienes I, Johnston E, Bitto N, Kaparakis-Liaskos M, Kufer T Front Immunol. 2022; 13:930882.

PMID: 35967403 PMC: 9367220. DOI: 10.3389/fimmu.2022.930882.